2001
DOI: 10.1212/wnl.57.2.271
|View full text |Cite
|
Sign up to set email alerts
|

Genomic organization of the dysferlin gene and novel mutations in Miyoshi myopathy

Abstract: This study confirms that the dysferlin gene is mutated in MM and LGMD2B and extends understanding of the timing of onset of the disease. Knowledge of the genomic organization of the gene will facilitate mutation detection and investigations of the molecular biologic properties of the dysferlin gene.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
113
1

Year Published

2001
2001
2015
2015

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 129 publications
(116 citation statements)
references
References 29 publications
2
113
1
Order By: Relevance
“…Two mutations lie within the DysfNC domain, a nested repeat sequence in many ferlins and several other proteins, whose function is unknown. Missense mutations within this domain in dysferlin have been linked to Miyoshi myopathy (Aoki et al, 2001;Matsumura et al, 1999) also indicating its importance.…”
Section: +mentioning
confidence: 99%
“…Two mutations lie within the DysfNC domain, a nested repeat sequence in many ferlins and several other proteins, whose function is unknown. Missense mutations within this domain in dysferlin have been linked to Miyoshi myopathy (Aoki et al, 2001;Matsumura et al, 1999) also indicating its importance.…”
Section: +mentioning
confidence: 99%
“…DYSF1 contains amino-acid (aa) residues 2 -245 and has high homology with myoferlin and otoferlin, while DYSF2 contains residues 1666 -1788 and shows no homology to any known human protein. 18 To generate DYSF1, a 740 bp fragment was PCR amplified from human muscle cDNA with forward primer (5 0 -CGA GAT CTC TGA GGG TCT TCA TCC TCT ATG-3 0 ) and reverse primer (5 0 -CTC AAG CTT AGC GGT AAC CTT GAC CAC AGG-3 0 ) and cloned into the TOPO 2.1 vector (Invitrogen, Carlsbad, CA, USA). To generate DYSF2, a 375 bp fragment was similarly PCR amplified with forward primer (5 0 -GGA TCC CTG GAG AAC AGG CT-3 0 ) and reverse primer (5 0 -GTC GAC CCA CAT CTG CAG CT-3 0 ) and also cloned into TOPO 2.1.…”
Section: Recombinant Antigen Productionmentioning
confidence: 99%
“…All were previously studied by conventional Western blot analysis for suspected dysferlinopathy. For mutation screening, individual exons of dysferlin were amplified from genomic DNA with Immolase (Bioline, Randolph, MA, USA) as described, 18 with minor modification (primers sequences available on request). Amplified products included intron/exon boundaries and all protein coding sequences.…”
Section: Immunoprecipitationmentioning
confidence: 99%
“…In skeletal muscle, dysferlin participates in membrane wound repair mechanisms (Bansal et al, 2003), and these repair mechanisms are thought to involve membrane fusion (Bansal et al, 2003;Lennon et al, 2003). Mutations in the gene encoding dysferlin cause limb girdle muscular dystrophy-2B (LGMD2B) and Miyoshi muscular dystrophy (MMD) (Aoki et al, 2001;Bashir et al, 1994;Liu et al, 1998). At present, there are no treatments available for these muscle-wasting diseases.…”
Section: Introductionmentioning
confidence: 99%